RobertTsuntzeChenMDMA

PubMed

• 8 citations
  Laboratory-based performance evaluation of PIMA CD4 + T-lymphocyte count point-of-care by lay-counselors in Kenya
  Clement Zeh, Charles E. Rose, Seth C Inzaule, Mitesh Desai, Fredrick Otieno, Felix Humwa, Benta Akoth, Paul Omolo, Robert T. Chen, Yenew Kebede, Taraz Samandari> ;Journal of Immunological Methods. 2017 Sep 1
• 14 citations
  Enhancing Vaccine Safety Capacity Globally
  Robert T. Chen, Tom T. Shimabukuro, David Martin, Patrick L.F. Zuber, Daniel Weibel, Miriam C. J. M. Sturkenboom> ;American Journal of Preventive Medicine. 2015 Dec 1
• 20 citations
  Enhancing vaccine safety capacity globally: A lifecycle perspective.
  Robert T Chen, Tom T Shimabukuro, David B Martin, Patrick L F Zuber, Daniel M Weibel, Miriam Sturkenboom> ;Vaccine. 2015 Nov 27
• 6 citations
  Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.
  Robert T. Chen, Dale J. Hu, Eileen M. Dunne, Michael W. Shaw, James I. Mullins, Supachai Rerks-Ngarm> ;Vaccine. 2011 Aug 18
• 15 citations
  Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies
  Robert T. Chen> ;Vaccine. 2004 May 7
• 21 citations
  Myocarditis: the unexpected return of smallpox vaccine adverse events.
  Robert T. Chen, J. Michael Lane> ;Lancet. 2003 Oct 25
• 15 citations
  Combination vaccines: postlicensure safety evaluation.
  Robert T. Chen, Vitali Pool, Hiroshi Takahashi, Bruce G. Weniger, Bindi Patel> ;Clinical Infectious Diseases. 2001 Dec 15
• 98 citations
  Epidemiology of autoimmune reactions induced by vaccination.
  Robert T. Chen, Robert Pless, Frank DeStefano> ;Journal of Autoimmunity. 2001 May 1
• Vaccine safety: current and future challenges.
  Chen, R. T.,Hibbs, B.> ;Pediatr Ann. 1998 Jul 25
• Join now to see all

Journal Articles

• Respiratory diphtheria in the United States, 1980-1995.  
  Bisgard KM, Hardy IRB, Popovic T, Strebel PM, Wharton M, Chen RT, Hadler SC, Am J Public Health 1998;88:787-91
• Comparative safety of two recombinant hepatitis b vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).  
  Niu MT, Rhodes P, Salive M, Lively T, Davis DM, Black S, Shinefield H, Chen RT, Ellenberg SS, and the VAERS and VSD working groups, J Clin Epidemiol 1998;51:503-10
• Epidemiology of Diarrheal Disease among Children Enrolled in Four West Coast Health Maintenance Organizations.  
  Parashar UD, Holman RC, Bresee JS, Clarke MJ, Rhodes PH, Davis RL, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Marcy M, Vadheim CM, Ward JI, Chen RT, Glass RI..., Pediatr Infect Dis J 1998;17:605-11
• Wheezing Lower Respiratory Disease and Vaccination of Full-Term Infants.  
  Mullooly JP, Pearson J, Drew L, Schuler R, Maher J, DeStefano F, Gargiullo P, Chen RT, and the Vaccine Safety Datalink (VSD) Working Group, Pharmacoepidemiology and Drug Safety 2002; 11(1):21-30
• Vaccine safety: current and future challenges.  
  Chen RT, Hibbs B, Ped Annals 1998;27:445-64
• Adverse events after Japanese Encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States.  
  Takahashi H, Pool V, Tsai TF, Chen RT, Vaccine 2000; 18: 2963-2969
• Addressing the challenges to immunization practice with an economic algorithm for vaccine selection.  
  Weniger BG, Chen RT, Jacobson SH, Sewell EC, Deuson R, Livengood JR, Orenstein WA, Vaccine 1998;16(19):1885-1897
• Quality of HMO vaccination databases used to monitor childhood vaccine safety.  
  Mullooly J, Drew L, DeStefano F, Chen R, Okoro K, Swint E, Immanuel V, Ray P, Lewis N, Vadheim C, Lugg M, and the Vaccine Safety Datalink Team, Am J Epidemiol 1999;149:186_94
• Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma.  
  Kramarz P, DeStefano F, Gargiullo PM, Lieu TA, Davis RL, Chen RT, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy MS, and the Vaccine Safety Datalink..., Arch Fam Med 2000;9:617-623
• Safety of Revaccination with Pneumococcal Polysaccharide Vaccine.  
  Jackson LA, Benson P, Sneller VP, Butler JC, Thompson RS, Chen RT, Lewis LS, Carlone G, DeStefano F, Holder P, Lezhava T, Williams WW, J Am Med Assoc 1999;281:243_248
• Safety of routine childhood vaccinations: an epidemiological review.  
  Chen RT, Mootrey G, DeStefano F, Paediatrics Drugs 2000;2:273-90
• Incidence of Kawasaki Syndrome in West Coast Health Maintenance Organizations.  
  Belay ED,Holman RC, Clarke MJ, DeStefano F, Shahriari A, Davis RL, Rhodes PH, Thompson RS, Black SB, Shinefield HR, Marcy SM, Ward JI, Mullooly JP, Chen RT, Schonberge..., Ped Infect Dis J; 2000;19:828-32
• Non-medical exemptions to state immunization laws: formal processes are associated with fewer exemptions.  
  Rota JS, Salmon DA, Rodewald LE, Chen RT, Hibbs BF, Gangarosa EJ, Am J Pub Health 2001;91:645-8
• Excess individual and community risks associated with personal exemptions to immunization: An evaluation of measles and pertussis in Colorado, 1987-1998.  
  Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman, RE, JAMA 2000;284:3145-50
• Does influenza vaccination prevent asthma exacerbations in children?  
  Kramarz P, DeStefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL,, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy MS, J Pediatr. 2001 Mar;138(3):306_10
• Principles of epidemiologic research on drug effects (letter).  
  Garguillo PM, Kramarz P, DeStefano F, Chen RT, Lancet 1999;353:501
• A Case-Control Study of MMR and Other Measles-Containing Vaccines and Risk for Inflammatory Bowel Disease. Results from the Vaccine Safety Datalink Study.  
  Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Drew L, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen RT for the Va..., Arch Pediatr Adolesc Med. 2001 Mar;155(3):354_359
• Population Based Study of Rotavirus Vaccination and Intussusception.  
  Kramarz P, France EK, Black SB, Shinefield H, Ward JI, Chang E, Destefano F, Chen RT, et al, Ped Infect Dis J 2001; 20:410-6
• Epidemiology of autoimmune reactions induced by vaccination.  
  Chen RT, Pless R, Destefano F, J Autoimmunity 2001;16:309-18
• The Vaccine Safety Datalink project.  
  DeStefano F and the Vaccine Safety Datalink Research Group, Pharmacoepidemiology and Drug Safety 2001; 10:1-4
• Adjuvanted pandemic influenza A (H1N1) 2009 vaccines and Guillain Barré syndrome (commentary).  
  DeStefano F, Vellozzi C, Schonberger LB, Chen RT, BMJ 2011; 343:d4159
• Safety of Thimerosal-Containing Vaccines: A Two-Phased Study of Computerized Health Maintenance Organization Databases.  
  Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT, for the Vaccine Safety Datalink team, Pediatrics 2003 Nov; 112:1039-48
• Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15–59 years of age.  
  Ray P, Black S, Shinefield H, Dillond A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R, and VSD Team, Vaccine 2011 Sep 2;29(38):6592-6597
• Modeling the impact of RV144-like vaccines on HIV transmission (commentary).  
  Hankins CA, Glasser JW, Chen RT, Vaccine 2011 Aug 18;29(36):6069-71
• Autism and MMR Vaccination: Controversy Laid to Rest?  
  Destefano F, Davis RL, Chen RT, CNS Drugs 2001;15:831-7
• Join now to see all

Books/Book Chapters

•  
  Chapter: Corynebacterial infections. 
  Page 1377 - 1380Chen RTEditors: Kelley WN.J B Lippincott, PhiladelphiaEdition 2,
•  
  Chapter: Chapter 272: Corynebacterial infections. 
  Page 1984 - 1986Chen RTJ B Lippincott, PhiladelphiaEdition 4,
•  
  Chapter: Corynebacterial infections. 
  Page 1377 - 1380Chen RTEditors: Kelley WN.J B Lippincott, PhiladelphiaEdition 2,
•  
  Chapter: Diphtheria 
  Chen RTMcGraw_Hill, New YorkEdition 9,
•  
  Chapter: Ch26: Special methodological issues in pharmacoepidemiology studies of vaccine safety. 
  Page 423 - 468Chen RT, Glanz, J, Vellozzi CEditors: Strom BL.John Wiley & Sons, SussexEdition 5,
•  
  Terracciano G, Chen R, Lloyd JCenters for Disease Control and Prevention, Atlanta, GA
•  
  Chapter: Chapter 278: Corynebacterial infections. 
  Page 1627 - 1629Chen RT, Hardy IRBEditors: Kelley WN.J B Lippincott, PhiladelphiaEdition 3,
•  
  Chapter: Vaccine preventable diseases: the commercially available vaccines. 
  Page 232 - 251Barnett ED, Chen RT, Rey MEditors: Dupont HL, Steffen R.Decker , MontrealEdition 2,
•  
  Chapter: Vigilancia epidemiologica de evento adversos despué de la vacunacion 
  Page 197 - 207Cordero JF, Chen REditors: Marti MC, Llop FAM.Prous Science, Barcelona
•  
  Chapter: Ch. 49: Safety of Vaccines. 
  Page 1144 - 1163Chen RTEditors: Plotkin SA, Orenstein WA.WB Saunders, PhiladelphiaEdition 3,
•  
  Chapter: Ch. 44: Vaccines for International Travel. 
  Page 1089 - 1106Barnett E, Chen RT, Rey MEditors: Plotkin SA, Orenstein WA.W.B. Saunders, PhiladelphiaEdition 3,
•  
  Chapter: Vaccine safety and adverse events: key issues for health care workers. 
  Page 37 - 60Terracciano GJ, Chen REditors: Poland GA, Schaffner W, Pugliese G.Slack Inc, Thorofare, NJ
•  
  Chapter: Challenges and Controversies in Immunization Safety. 
  Page 21 - 39Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs BEditors: Peter G, Gardner P.Peter G, Gardner P
•  
  Chapter: Evaluation of Immunization Programs. 
  Page 344 - 372Chen RT, Orenstein WAEditors: Thomas JC, Weber DJ.Oxford University Press , Oxford
•  
  Chapter: Ch. 61: Safety of Immunizations. 
  Page 1557 - 1581Chen RT, Davis R, Sheedy KMEditors: Plotkin SA, Orenstein WA.W.B. Saunders, PhiladelphiaEdition 4,
•  
  Chapter: Special Applications of Pharmacoepidemiology 
  Page 399 - 445Lee D, Majumdar SR, Lipton HL, Soumerai SB, Hennessy S, Davis RL, Chen RT, Bright RA, Mitchell AA, Graham DJ, Bates DW, and Strom BLEditors: Strom BL & Kimmel SE.John Wiley & Sons, Sussex
•  
  Chapter: Ch. 18: Vaccine preventable diseases PART 2: Public health surveillance for vaccine adverse events. 
  Page 241 - 253Iskander JK, Chen RTEditors: M'ikanatha NM, Lynfield R, Van Beneden CA, de Valk H.Wiley-Blackwell , OxfordEdition 1,
•  
  Chapter: Ch31: Rotavirus vaccines. 
  Page 745 - 749Sabin ME, Murphy TV, Chen RTEditors: Hartzema AG, Tilson HH, Chan KA.Harvey Whitney Books , CincinnatiEdition 1,
•  
  Chapter: Vaccine safety monitoring. 
  Iskander JK, Chen RTEditors: Sheikh NA, Davies DH, Schmidt C, Morrow, WJW.Wiley-Blackwell, OxfordEdition 1,
•  
  Chapter: Recent developments in vaccines for travellers: viral diseases. 
  Chen RT, Orenstein WAEditors: Lobel HO, Steffen R, Kozarsky PE.International Society of Travel Medicine, 1992:119-21, Atlanta, GA
•  
  Chapter: The Vaccine Adverse Event Reporting System (VAERS): a new resource for data on vaccine safety for travelers. 
  Chen RTEditors: Lobel HO, Steffen R, Kozarsky PE.Society of Travel Medicine, 1992:128-30, Atlanta, GA
• Join now to see all

Abstracts/Posters

• Yellow Fever Vaccine Safety Working Group. Thymus disease as a potential risk factor for yellow fever vaccine-associated viscerotropic disease (YEL-AVD).
  Barwick Eidex R, Miller E, Russell MN, Teuwen D, Montah T, Hayes EB, Marfin A, Iskander J, Chen R, Cetron MS, Yellow Fever Vaccine Safety Working Group, 53rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Miami, FL
• Making Medical Injection Safer: A Major Step towards Enhancing Patient Safety in Developing Countries.
  Chen RT, Post G, Millogo J, Van Roekel K, Catlin M, Clark K, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Monitoring of Vaccine Safety Inquiries: A New Tool for Vaccine Safety Signal Generation.
  Miller ER, Iskander JK, Haber P, Gangarosa P, Pool V, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• ASSIGN: A Proactive Systematic Approach to Vaccine-Vigilance in the U.S. Vaccine Adverse Event Reporting System.
  Pool V, James SP, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Investigation of Deaths and Serious Illnesses Following Influenza Vaccination in a Long-Term Care Facility.
  Rue AM, Lyn S, Iskander JK, Bloestein J, Gargiullo P, Shadomy S, Seward J, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Sensorineural Hearing Loss Following Measles-Mumps-Rubella Vaccination: Vaccine Adverse Event Reporting System, United States, 1991–2004.
  Asatryan A, Pool V, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Kenya’s “Top down approach” to improve rational injections.
  Chen RT, Songa J, Mwangi J, Lore B, Khan F, Global Injection Safety and Infection Control Meeting, Mexico City, Mexico
• Fabrication and analysis of plastic hypodermic needles.
  Colton JS, Chen R, Global Injection Safety and Infection Control Meeting, Mexico City, Mexico
• A model to budget for sharps waste management in resource-scarce settings.
  Chen R, Catlin M, Lasley J, Songa J, Millogo J, Ferris R, Post G, Global Injection Safety and Infection Control Meeting, Mexico City, Mexico
• AIDS Vaccines Update: Making Sense of the Vaccine Development Process – Basic Research Literacy and Lessons Learned from Vaccine History.
  Chen RT, A Collaborative Symposium in advance of the AIDS Vaccine Conference 2008, Capetown, South Africa
• Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG): Maximizing the Comparability and Value of Safety Data from HIV Vaccine Trials.
  Chen, RT; Excler JL2; Laderoute M3; Mahy B1; Hendry M1; Via Cl; Compingbutra A1; Gidudu J1 on behalf of the V3SWG, AIDS Vaccine 2009, Paris, France
• Safety, tolerability, and immunogenicity of varying doses of influenza vaccine administered by jet injector vs. needle and syringe.
  Jackson LA, Chen RT, Austin G, Stout R, Gorse GJ, Weniger B, Yu O, Destefano F and the VSD Team, 3rd Annual Conference on Vaccine Research, Washington, DC
• Still-blinded Safety and Immunogenicity Data from a Trial of Reduced-dose, Intradermal, Influenza Vaccination by Needle-free Jet Injection.
  Gomez V, Palomeque FS, Feris J, Fernández J, Sánchez J, Moro PL, Mota1 CS, Sánchez V, Guzmán G, Bridges CB, Bresee JS, Friede M, Zehrung D, Chen RT, Weniger BG, Thirteenth Annual Conference on Vaccine Research, Bethesda, Maryland
• Enhancing the Vaccine Adverse Event Reporting System (VAERS) To Assess Risk: A Capture_Recapture Analysis of Intussusception after Rotavirus Vaccination.
  Verstraeten TM, Baughman AL, Haber P, Chen RT, 16th International Conference on Pharmacoepidemiology, Barcelona
• Preparing for the availability of a partially effective HIV vaccine.
  Chen RT, Hankins C, Osmanov S, Esparza J, Michael NL, McCluskey M, Warren M, AIDS Vaccine 2011, Bangkok, Thailand
• Hepatitis B vaccination and demyelinating diseases – an interim analysis from the Vaccine Safety Datalink.
  DeStefano F, Jackson LA, Okoro CA, Chen RT, 16th International Conference on Pharmacoepidemiology, Barcelona, Spain
• Evaluation of different data mining approaches for signal detection in the Vaccine Adverse Event Reporting System (VAERS).
  Pool V, Barker L, Chen RT, 16th International Conference on Pharmacoepidemiology, Barcelona, Spain
• Rotavirus vaccine reports to the Vaccine Adverse Event Reporting System (VAERS) – assessing safety profiles of non-intussusception reports.
  Haber P, Mootrey G, Verstraeten TM, Pless R, Zanardi L, Chen RT, 16th International Conference on Pharmacoepidemiology, Barcelona, Spain
• Risk of wheezing lower respiratory disease in infants after vaccination.
  Mullooly JP, Pearson J, Drew L, Schuler R, Garguillo P, Destefano F, Chen R, 16th International Conference on Pharmacoepidemiology, Barcelona, Spain
• The impact of vaccination on varicella incidence, conditional on school attendance and temperature, in Antelope Valley, CA.
  Goldman GS, Glasser JW, Maupin TJ, Peterson CL, Mascola L, Chen RT, Seward JF, 16th International Conference on Pharmacoepidemiology, Barcelona, Spain
• Vaccine Adverse Event Reporting System (VAERS), U.S. 1991-1999, a 9 year experience.
  Haber P, Mootrey GJ, Pless R, Chen RT, 16th International Conference on Pharmacoepidemiology, Barcelona, Spain
• Childhood Vaccinations and Type 1 Diabetes.
  DeStefano F, Okoro CA, Mullooly JP, Chen RT, 17th International Conference on Pharmacoepidemiology, Toronto, Canada
• Risk of Seizures Following Acellular Pertussis Vaccine - Results from a Large Linked Safety Database.
  Kohl KS, Hur Y, Rhodes P, Davis R, Chen R, 17th International Conference on Pharmacoepidemiology, Toronto, Canada
• Varicella Vaccine Failure in Children with Asthma.
  Verstraeten T, Mullooly JP, Izurieta H, Jumaan A, Seward J, DeStefano F, Chen RT, 17th International Conference on Pharmacoepidemiology, Toronto, Canada
• Reporting Trends of Hypersensitivity Reactions in VAERS Following Live Virus Vaccines Containing Gelatin.
  Pool V, Pless RP, Chen RT, 17th International Conference on Pharmacoepidemiology, Toronto, Canada
• Join now to see all

Lectures

• Vaccine Safety Monitoring: A New Imperative for Immunization Programs. 
  Korean Conference on Emerging Infectious Diseases, Seoul, Korea
• Vaccine Safety Update. 
  Association of State and Territorial Health Officials (ASTHO) Infectious Disease Policy Committee
• Establishing Causality in Vaccine Safety Studies: Lines of Evidence. 
  Pan American Health Organization (PAHO), (EPI), (TAG) Meeting, Iguasu Falls, Brazil
• Update on Vaccine Safety Monitoring in the U.S.: Sustaining Mature Immunization Programs. 
  World Vaccine Congress, Paris, France
• Vaccine Safety. Vaccines are beneficial! What are the risks? 
  Berzelius symposium on vaccines, Stockholm, Sweden
• Update on Vaccine Safety. 
  7th Conference of the International Society of Travel Medicine, Innsbruck, Austria
• Vaccine Triggers for Intussusception? and Measuring Vaccines: Benefits and Risks. 
  41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, IL
• Maintaining Public Confidence in Immunizations: Role of Vaccine Safety at CDC. 
  AAP Chapter Advocacy Summit, Atlanta, Georgia
• La seguridad de las vacunaciones sistemáticas. 
  First Congress of the Spanish Association of Vaccinology, Cadiz, Spain
• Issues in Vaccine Safety. 
  41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL
• Vaccine Safety: A Cumulative Scientific Endeavor and Combination Vaccines: Meeting the New Opportunities and Challenges. 
  7th annual Massachusetts Immunization Action Partership, Worchester, MA
• Cohort and case-control studies in the evaluation of safety of vaccines. 
  The First International Symposium on The Evaluation of The Safety of Human Vaccines, Rome, Italy
• CDC Perspective. 
  New York State Vaccine Safety Summit. Cooperstown, NY
• Symposia on Vaccine Safety. 
  Pediatric Infectious Disease Society Conference, San Diego CA
• Immunization Safety: An Emerging Imperative. 
  American College of Clinical Pharmacy Annual Meeting, Atlanta, GA
• Vaccine Safety: An Emerging Imperative. 
  Symposium of the Dutch Society for Infection Diseases, Utrecht, The Netherlands
• SIGN: some insights from inception to implementation. 
  Global Injection Safety and Infection Control Meeting
• Plastic Hypodermic Needles: An Affordable "Green" Solution to the Iatrogenic Disaster of Unsafe Injections. 
  CDC Technology Forum, Atlanta, GA
• Case Studies of possible evaluations that would use a global vaccine safety data net: HIV vaccine. 
  Global Vaccine Safety DataNet Meeting
• Enhancing vaccine safety assessment during vaccine development: some modest proposals. 
  2nd Global Congress on Vaccine, Boston, MA, USA
• Science and Practice: Establishing the Evidence for Vaccines: the intriguing tale of Diphtheria: from von Behring to Moscow. 
  ECDC, Stockholm, Sweden
• Vaccine Safety Strategic Issues. Distributed Networks: Opportunities and Challenges. 
  International Society of Pharmacoepidemiology Mid-Year Symposium
• HIV Vaccine: The Spring after a Long Winter? and A “Lifecycle” Approach to Vaccine Safety: Global Trends and Challenges. 
  5th Asian Congress of Pediatric Infectious Diseases, Taipei, Taiwan
• Optimal safety assessment system for future vaccines against poverty-related diseases (PRD:HIV, malaria, TB) in developing countries. 
  Meeting on Post-licensure Evaluation of Vaccine Safety: Current Status and Future Directions.
• Join now to see all

Other

• Infant Immunization With Acellular Pertussis Vaccines in the United States:Assessment of the First Two Years' Data From the Vaccine Adverse Event Reporting System (VAE... 
  Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS, and the VAERS Working Group, Pediatrics 2000;106(4)
  http://www.pediatrics.org/cgi/content/full/106/4/e51
• Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. 
  DeStefano F, Mullooly J, Okoro K, Chen RT, Vadheim C, Marcy M, Ward J, Black S, Shinefield H, Davis R, Bohlke K, Pediatrics 2001; 108(6)
  http://www.pediatrics.org/cgi/content/full/108/6/e112
• Surveillance for poliovirus vaccine adverse events, 1991-1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral polioviru... 
  Wattigney WA, Mootrey GT, Braun MM, Chen RT, Pediatrics 2001;107(5)
  http://www.pediatrics.org/cgi/content/full/107/5/e83
• The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization. Advances in Patient Safety: Fr... 
  Kohl K, Bonhoeffer J, Braun MM, Chen R, Duclos P, Heijbel H, Heininger U, Loupi E, Marcy SM, and The Brighton Collaboration, AHRQ Publication Nos. 0500212
  http://www.ahrq.gov/qual/advances/
  Agency for Healthcare Research and Quality, Rockville, MD
• A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use and measles-mumps-rubella vaccination. 
  Verstraeten T, Jumaan A, Mullooly J, Seward J, Izurieta H, DeStefano F, Black S, Chen R, and the Vaccine Safety Datalink Research Group, Pediatrics 2003 Aug;112:e98 –e103
  http://www.pediatrics.org/cgi/content/full/112/2/e98
• Join now to see all